8270 D
8270 D
8270 D
In addition, SW-846 methods, with the exception of required method use for the analysis
of method defined parameters (MDPs), are intended to be guidance methods that contain
general information on how to perform an analytical procedure or technique, which a laboratory
can use as a basic starting point for generating its own detailed standard operating procedure
(SOP), either for its own general use or for a specific project application. The performance data
included in this method are for guidance purposes only, and are not intended to be and must not
be used as absolute quality control (QC) acceptance criteria for purposes of laboratory
accreditation.
a
Chemical Abstract Service (CAS) Registry Number
b
See Sec. 1.2 for other acceptable preparation methods.
c
Chemical name was changed by the Integrated Risk Information System (IRIS) on November
30, 2007 from Bis(2-chloroisopropyl)ether to Bis(2-chloro-1-methylethyl)ether (common name).
This compound is also known as 2,2’-oxybis(1-chloropropane) (CAS index name). See the link
at http://www.epa.gov/iris/subst/0407.htm, Section VII for the “Revision History” and Section
VIII, for “Synonyms” of this chemical.
1.2 In addition to the sample preparation methods listed in the above analyte list,
Method 3535 describes a solid-phase extraction (SPE) procedure that may be applied to the
extraction of semivolatiles from toxicity characteristic leaching procedure (TCLP) leachates (see
Tables 16 and 17 of this method for performance data). Method 3542 describes sample
preparation for semivolatile organic compounds in air sampled by Method 0010 (see Table 10 of
this method for surrogate performance data), Method 3545 describes an automated solvent
extraction (ASE) device for semivolatiles in solids (see Table 11 of this method for performance
data), Method 3561 describes a supercritical fluid extraction (SFE) device for the extraction of
polynuclear aromatic hydrocarbons (PAHs) from solids (see Tables 12, 13, and 14 of this
SW-846 Update V 8270D - 6 Revision 5
July 2014
method for performance data), and Method 3546 provides an extraction procedure employing
commercially available microwave equipment to extract semivolatiles while using less solvent
and taking less time than procedures such as a Soxhlet extraction (see Tables 18 through 22 of
this method for the applicable performance data). The tabulated data are provided for guidance
purposes only.
1.3 This method can be used to quantitate most neutral, acidic, and basic organic
compounds that are soluble in methylene chloride (or other suitable solvents provided that the
desired performance data can be generated) and are capable of being eluted, without
derivatization, as sharp peaks from a gas chromatographic fused-silica capillary column coated
with a slightly polar silicone. Such compounds include PAHs, chlorinated hydrocarbons and
pesticides, phthalate esters, organophosphate esters, nitrosamines, haloethers, aldehydes,
ethers, ketones, anilines, pyridines, quinolines, aromatic nitro compounds, and phenols,
including nitrophenols. See Table 1 for a list of compounds and their characteristic ions that
have been evaluated.
In most cases, this method is not appropriate for the quantitation of multicomponent
analytes (e.g., Aroclors, toxaphene, chlordane, etc.) because of limited sensitivity for those
analytes. When these analytes have been identified by another technique, Method 8270 may
be appropriate for confirmation of the identification of these analytes when concentration in the
extract permits. Refer to Methods 8081 and 8082 for guidance on calibration and quantitation of
multicomponent analytes such as the Aroclors, Toxaphene, and Chlordane.
1.4 The following compounds may require special treatment when being determined by
this method:
1.4.2 Under the alkaline conditions of the extraction step from aqueous
matrices, α-BHC, γ-BHC, endosulfan I and II, and endrin are subject to decomposition.
Neutral extraction should be performed if these compounds are expected to be present.
1.4.8 Pyridine may perform poorly at the GC injection port temperatures listed
in this method. Lowering the injection port temperature may reduce the amount of
degradation. However, the analyst must use caution in modifying the injection port
temperature, as the performance of other analytes may be adversely affected. Therefore,
if pyridine is to be determined in addition to other target analytes, it may be necessary to
perform separate analyses. In addition, pyridine may be lost during the evaporative
concentration of the sample extract. As a result, many of the extraction methods listed
above may yield low recoveries unless great care is exercised during the concentration
steps. For this reason, analysts may wish to consider the use of extraction techniques
such as pressurized fluid extraction (Method 3545), microwave extraction (Method 3546),
or supercritical fluid extraction, which involve smaller extract volumes, thereby reducing or
eliminating the need for evaporative concentration techniques for many applications.
1.4.9 Toluene diisocyanate rapidly hydrolyzes in water (it has a half-life of less
than 30 min). Therefore, recoveries of this compound from aqueous matrices should not
be expected. In addition, in solid matrices, toluene diisocyanate often reacts with alcohols
and amines to produce urethane and ureas and consequently cannot usually coexist in a
solution containing these materials.
1.4.10 In addition, analytes in the list provided above are flagged when there are
limitations caused by sample preparation and/or chromatographic problems.
1.5 The lower limits of quantitation (LLOQ) for this method when determining an
individual compound are approximately 660 µg/kg (wet weight) for soil/sediment samples, 1-200
mg/kg for wastes (dependent on matrix and method of preparation), and 10 µg/L for
groundwater samples (see Table 2). LLOQ will be proportionately higher for sample extracts
that require dilution to avoid saturation of the detector. The lower limits of quantitation listed in
Table 2 are provided for guidance and may not always be achievable.
1.6 Prior to employing this method, analysts are advised to consult the base method
for each type of procedure that may be employed in the overall analysis (e.g., Methods 3500,
3600, 5000, and 8000) for additional information on QC procedures, development of QC
acceptance criteria, calculations, and general guidance. Analysts also should consult the
disclaimer statement at the front of the manual and the information in Chapter Two for guidance
on the intended flexibility in the choice of methods, apparatus, materials, reagents, and
supplies, and on the responsibilities of the analyst for demonstrating that the techniques
employed are appropriate for the analytes of interest, in the matrix of interest, and at the levels
of concern.
In addition, analysts and data users are advised that, except where explicitly specified in a
regulation, the use of SW-846 methods is not mandatory in response to Federal testing
requirements. The information contained in this method is provided by Environmental
Protection Agency (EPA or the Agency) as guidance to be used by the analyst and the
regulated community in making judgments necessary to generate results that meet the data
quality objectives (DQOs) for the intended application.
1.7 Use of this method is restricted to use by, or under supervision of, personnel
appropriately experienced and trained in the use of the GC/mass spectrometer (MS) and skilled
in the interpretation of mass spectra. Each analyst must demonstrate the ability to generate
acceptable results with this method.
2.1 The samples are prepared for analysis by GC/MS using the appropriate sample
preparation (refer to Method 3500) and, if necessary, sample cleanup procedures (refer to
Method 3600).
2.2 The semivolatile compounds are introduced into the GC/MS by injecting the
sample extract into a GC equipped with a narrow-bore fused-silica capillary column. The GC
column is temperature-programmed to separate the analytes, which are then detected with an
MS connected to the GC.
2.3 Analytes eluted from the capillary column are introduced into the MS via a jet
separator or a direct connection. Identification of target analytes is accomplished by comparing
their mass spectra with the electron impact (or electron impact like) spectra of authentic
standards. Quantitation is accomplished by comparing the response of a major (quantitation)
ion relative to an internal standard using an appropriate calibration curve for the intended
application.
2.4 This method includes specific calibration and QC steps that supersede the general
recommendations provided in Method 8000.
3.0 DEFINITIONS
Refer to Chapter One and the manufacturer's instructions for definitions that may be
relevant to this procedure.
4.0 INTERFERENCES
4.1 Solvents, reagents, glassware, and other sample processing hardware may yield
artifacts and/or interferences to sample analysis. All of these materials must be demonstrated
to be free from interferences under the conditions of the analysis by analyzing method blanks.
Specific selection of reagents and purification of solvents by distillation in all glass systems may
be necessary. Refer to each method to be used for specific guidance on QC procedures and to
Chapter Four for general guidance on the cleaning of glassware. Also refer to Method 8000 for
a discussion of interferences.
4.2 Raw gas chromatography/mass spectrometry data from all blanks, samples, and
spikes must be evaluated for interferences. Determine if the source of interference is in the
preparation and/or cleanup of the samples and take corrective action to eliminate the problem.
4.3 Contamination by carryover can occur whenever high concentration and low
concentration samples are sequentially analyzed. To reduce carryover, the sample syringe
must be rinsed with solvent between sample injections. Whenever an unusually concentrated
sample is encountered, it should be followed by the analysis of solvent to check for cross-
contamination.
This method does not address all safety issues associated with its use. The laboratory is
responsible for maintaining a safe work environment and a current awareness file of
Occupational Safety and Health Administration (OSHA) regulations regarding the safe handling
of the chemicals listed in this method. A reference file of material safety data sheets (MSDSs)
should be available to all personnel involved in these analyses.
The mention of trade names or commercial products in this manual is for illustrative
purposes only, and does not constitute an EPA endorsement or exclusive recommendation for
use. The products and instrument settings cited in SW-846 methods represent those products
and settings used during method development or subsequently evaluated by the Agency.
Glassware, reagents, supplies, equipment, and settings other than those listed in this manual
may be employed provided that method performance appropriate for the intended application
has been demonstrated and documented.
This section does not list common laboratory glassware (e.g., beakers and flasks).
6.1.5 Data system - A computer system should be interfaced to the MS. The
system must allow the continuous acquisition and storage on machine-readable media of
all mass spectra obtained throughout the duration of the chromatographic program. The
computer should have software that can search any gas chromatography/mass
spectrometry data file for ions of a specific mass and that can plot such ion abundances
versus time or scan number. This type of plot is defined as an Extracted Ion Current
Profile (EICP). Software should also be available that allows integrating the abundances
in any EICP between specified time or scan number limits. The most recent version of the
EPA/National Institute of Standards and Technology (NIST) Mass Spectral Library should
also be available.
6.2 Syringe - 10 µL
6.3 Volumetric flasks, Class A - Appropriate sizes equipped with ground-glass stoppers
7.1 Reagent-grade chemicals must be used in all tests. Unless otherwise indicated, it
is intended that all reagents conform to the specifications of the Committee on Analytical
Reagents of the American Chemical Society (ACS), where such specifications are available.
Other grades may be used, provided it is first ascertained that the reagent is of sufficiently high
purity to permit its use without lessening the accuracy of the determination. Reagents should be
stored in glass to prevent the leaching of contaminants from plastic containers.
7.2 Organic-free reagent water - All references to water in this method refer to organic-
free reagent water.
The following sections describe the preparation of stock, intermediate, and working
standards for the compounds of interest. This discussion is provided as an example, and other
approaches and concentrations of the target compounds may be used, as appropriate for the
intended application. See Method 8000 for additional information on the preparation of
calibration standards.
7.4 Stock standard solutions (1000 mg/L) - Standard solutions can be prepared from
pure standard materials or purchased as certified solutions.
7.4.2 Transfer the stock standard solutions into bottles equipped with PTFE-
lined screw caps. Store, protected from light, at ≤6 °C or as recommended by the
standard manufacturer. Stock standard solutions should be checked frequently for signs
of degradation or evaporation, especially just prior to preparing calibration standards from
them.
7.4.3 Stock standard solutions must be replaced after one year or sooner if
comparison with QC check samples indicates a problem.
7.4.5 Mixes with hydrochloride salts may contain hydrochloric acid, which can
cause analytical difficulties. When using a premixed certified standard, consult the
manufacturer's instructions for additional guidance.
7.7.1 It is the intent of EPA that all target analytes for a particular analysis be
included in the calibration standard(s). These target analytes may not include the entire
list of analytes (Sec. 1.1) for which the method has been demonstrated. However, the
laboratory shall not report a quantitative result for a target analyte that was not included in
the calibration standard(s).
NOTE: In the presence of samples containing residual chlorine, phenol-d6 has been known to
react to form chlorinated phenolic compounds that are not detected as the original
spiked surrogate. Sample preservation precautions outlined in Chapter Four should be
used when residual chlorine is known to be present in order to minimize degradation of
deuterated phenols or any other susceptible target analyte.
NOTE: Method 3561 (SFE Extraction of PAHs) recommends the use of bromobenzene
and p-quaterphenyl to better cover the range of PAHs listed in the method.
7.9 Matrix spike and laboratory control standards (LCSs) - See Method 3500 for
instructions on preparing the matrix spike standard. The same standard may be used as the
LCS and the spiking solution should be the same source as used for the initial calibration
standards to restrict the influence of standard accuracy on the determination of recovery
through preparation and analysis.
7.9.3 Some projects may require the spiking of the specific compounds of
interest, since the spiking compounds listed in Method 3500 would not be representative
of the compounds of interest required for the project. When this occurs, the matrix and
LCS spiking standards should be prepared in methanol, with each compound present at a
concentration appropriate for the project.
8.2 Store the sample extracts at ≤6 °C, protected from light, in sealed vials (e.g.,
screw-cap vials or crimp-capped vials) equipped with unpierced PTFE-lined septa.
9.1 Refer to Chapter One for guidance on quality assurance (QA) and QC protocols.
When inconsistencies exist between QC guidelines, method-specific QC criteria take
precedence over both technique-specific criteria and those criteria given in Chapter One, and
technique-specific QC criteria take precedence over the criteria in Chapter One. Any effort
involving the collection of analytical data should include development of a structured and
systematic planning document, such as a quality assurance project plan (QAPP) or a sampling
and analysis plan (SAP), which translates project objectives and specifications into directions for
those that will implement the project and assess the results. Each laboratory should maintain a
formal QA program. The laboratory should also maintain records to document the quality of the
data generated. All data sheets and QC data should be maintained for reference or inspection.
9.2 Refer to Method 8000 for specific determinative method QC procedures. Refer to
Method 3500 or 5000 for QC procedures to ensure the proper operation of the various sample
preparation techniques. If an extract cleanup procedure is performed, refer to Method 3600 for
the appropriate QC procedures. Any more specific QC procedures provided in this method will
supersede those noted in Methods 8000, 5000, 3500, or 3600.
9.3.1 The GC/MS must be tuned to meet the recommended DFTPP criteria
prior to the initial calibration and for each twelve-hour period during which analyses are
performed. See Secs. 11.3.1 and 11.4.1 for further details.
9.3.3 The GC/MS system must meet the calibration verification acceptance
criteria in Sec. 11.4.
9.3.4 The relative retention time (RRT) of the sample component must fall
within the RRT window of the standard component provided in Sec. 11.6.1.
9.5 Initially, before processing any samples, the analyst should demonstrate that all
parts of the equipment in contact with the sample and reagents are interference-free. This is
accomplished through the analysis of a method blank. As a continuing check, each time
samples are extracted, cleaned up, and analyzed, a method blank must be prepared and
analyzed for the compounds of interest as a safeguard against chronic laboratory
contamination. If a peak is observed within the retention time window of any analyte that would
prevent the determination of that analyte, determine the source and eliminate it, if possible,
before processing the samples. The blanks should be carried through all stages of sample
preparation and analysis. When new reagents or chemicals are received, the lab should
monitor the preparation and/or analysis blanks associated with samples for any signs of
contamination. It is not necessary to test every new batch of reagents or chemicals prior to
sample preparation if the source shows no prior problems. However, if reagents are changed
during a preparation batch, separate blanks need to be prepared for each set of reagents.
The laboratory must also have procedures for documenting the effect of the matrix on
method performance (precision, accuracy, method sensitivity). At a minimum, this should
include the analysis of QC samples including a method blank, a matrix spike, a duplicate, and a
LCS in each analytical batch and the addition of surrogates to each field sample and QC sample
when surrogates are used. Any method blanks, matrix spike samples, and replicate samples
should be subjected to the same analytical procedures (Sec. 11.0) as those used on actual
samples.
9.6.1 Documenting the effect of the matrix should include the analysis of at
least one matrix spike and one duplicate unspiked sample or one matrix spike/matrix spike
duplicate pair. The decision on whether to prepare and analyze duplicate samples or a
matrix spike/matrix spike duplicate must be based on knowledge of the samples in the
sample batch. If samples are expected to contain target analytes, laboratories may use a
matrix spike and a duplicate analysis of an unspiked field sample. If samples are not
expected to contain target analytes, then laboratories should use a matrix spike and matrix
spike duplicate pair. Consult Method 8000 for information on developing acceptance
criteria for the matrix spike and matrix spike duplicate.
9.6.2 An LCS should be included with each analytical batch. The LCS consists
of an aliquot of a clean (control) matrix similar to the sample matrix and of the same weight
or volume. The LCS is spiked with the same analytes at the same concentrations as the
matrix spike, when appropriate. When the results of the matrix spike analysis indicate a
potential problem due to the sample matrix itself, the LCS results are used to verify that
the laboratory can perform the analysis in a clean matrix. Consult Method 8000 for
information on developing acceptance criteria for the LCS.
9.6.3 Also see Method 8000 for the details on carrying out sample QC
procedures for preparation and analysis. In-house method performance criteria for
evaluating method performance should be developed using the guidance found in Method
8000.
9.6.4 Blanks – Before processing any samples, the analyst should demonstrate
through the analysis of a method blank that equipment and reagents are free from
contaminants and interferences. If a peak is found in the blank that would prevent the
identification or bias the measurement of an analyte, the analyst should determine the
source and eliminate it, if possible. As a continuing check, each time a batch of samples
is extracted, cleaned up, and analyzed, and when there is a change in reagents, a method
blank must be prepared and analyzed for the compounds of interest as a safeguard
against chronic laboratory contamination. Method blanks, trip blanks, and other field
blanks should be carried through all stages of sample preparation and analysis. At least
one method blank or instrument blank must be analyzed on every instrument after
calibration standard(s) and prior to the analysis of any samples.
9.6.7 When new reagents or chemicals are received, the lab should monitor the
blanks associated with samples for any signs of contamination. It is not necessary to test
every new batch of reagents or chemicals prior to sample preparation if the source shows
no prior problems. However, if reagents are changed during a preparation batch, separate
blanks need to be prepared for each set of reagents.
9.6.8 Method and/or solvent blanks may also be used to check for
contamination by carryover from a high-concentration sample into subsequent samples
(Sec. 4.2). When analysis of such blanks is not possible, such as when an unattended
autosampler is employed, the analyst should carefully review the results for at least the
next sample after the high-concentration sample. If analytes in the high-concentration
sample are not present in the subsequent sample, then lack of carryover has been
demonstrated. If there is evidence that carryover may have occurred, then the affected
samples should be reanalyzed.
If surrogates are used, the laboratory should evaluate surrogate recovery data from
individual samples versus the surrogate control limits developed by the laboratory. See Method
8000 for information on evaluating surrogate data and developing and updating surrogate limits.
Procedures for evaluating the recoveries of multiple surrogates and the associated corrective
actions should be defined in an approved project plan.
9.9 It is recommended that the laboratory adopt additional QA practices for use with
this method. The specific practices that are most productive depend upon the needs of the
laboratory and the nature of the samples. Whenever possible, the laboratory should analyze
standard reference materials and participate in relevant performance evaluation studies.
The LLOQ is the lowest concentration at which the laboratory has demonstrated target
analytes can be reliably measured and reported with a certain degree of confidence, which must
be ≥ the lowest point in the calibration curve. The laboratory shall establish the LLOQ at
concentrations where both quantitative and qualitative requirements can consistently be met
(see Sections 9.9 and 11.6). The laboratory shall verify the LLOQ at least annually, and
whenever significant changes are made to the preparation and/or analytical procedure, to
9.10.1 LLOQ Verification – The verification of LLOQs using spiked clean control
material represents a best-case scenario because it does not evaluate the potential matrix
effects of real-world samples. For the application of LLOQs on a project-specific basis,
with established DQOs, a representative matrix-specific LLOQ verification may provide a
more reliable estimate of the lower quantitation limit capabilities.
9.10.2 The LLOQ verification (to be performed after the initial calibration) is
prepared by spiking a clean control material with the analyte(s) of interest at 0.5-2 times
the LLOQ concentration level(s). Alternatively, a representative sample matrix free of
targets may be spiked with the analytes of interest at 0.5-2 times the LLOQ concentration
levels. The LLOQ check is carried through the same preparation and analytical
procedures as environmental samples and other QC samples. It is recommended to
analyze the LLOQ verification on every instrument where data is reported; however, at a
minimum, the lab should rotate the verification among similar analytical instruments such
that all are included within 3 years. Frequently performed analyses, such as 8270D,
should have an LLOQ check standard be verified, at minimum, once a year.
11.0 PROCEDURE
11.1.1 Samples are normally prepared by one of the following methods prior to
gas chromatography/mass spectrometry analysis.
11.1.2 In very limited applications, direct injection of the sample into the GC/MS
system with a 10-µL syringe may be appropriate. The quantitation limit is very high
(approximately 10,000 µg/L) when this procedure is used. Therefore, it is only appropriate
where concentrations in excess of 10,000 µg/L are expected.
11.2 Extract cleanup - Cleanup procedures may not be necessary for a relatively clean
sample matrix, but most extracts from environmental and waste samples will require additional
preparation before analysis. The specific cleanup procedure used will depend on the nature of
the sample to be analyzed and the DQOs for the measurements. General guidance for sample
extract cleanup is provided in this section and in Method 3600.
BC
Tailing Factor =
AB
11.3.2 The internal standards selected in Sec. 7.5 should permit most of the
components of interest in a chromatogram to have retention times of 0.80-1.20 relative
to one of the internal standards. Use the base peak ion from the specific internal
standard as the primary ion for quantitation (see Table 1). If interferences are noted,
use the next most intense ion as the quantitation ion (e.g., for 1,4-dichlorobenzen-d4, use
m/z 150 for quantitation).
Calculate response factors (RFs) for each target analyte relative to one of the
internal standards (see Table 4) as follows:
A s × C is
RF =
A is × C s
where:
As = Peak area (or height) of the analyte or surrogate
Ais = Peak area (or height) of the internal standard
Cs = Concentration of the analyte or surrogate, in µg/L
Cis = Concentration of the internal standard, in µg/L
n n
∑ RF
i =1
i ∑(RF − RF)
i
2
mean RF = RF = SD = i =1
n n -1
SD
RSD = × 100
RF
where:
RFi = RF for each of the calibration standards
RF = mean RF for each compound from the initial calibration
n = Number of calibration standards, e.g., 5
SD = Standard deviation
11.3.4.2 If more than 10% of the compounds included with the initial
calibration exceed the 20% RSD limit and do not meet the minimum correlation
coefficient (0.99) for alternative curve fits, then the chromatographic system is
considered too reactive for analysis to begin. Clean or replace the injector liner
and/or capillary column, then repeat the calibration procedure beginning with Sec.
11.3.
11.3.5 Evaluation of retention times - The RRT of each target analyte in each
calibration standard should agree within 0.06 RRT units. Late-eluting target analytes
usually have much better agreement.
11.3.6 Linearity of target analytes - If the RSD of any target analyte is 20% or
less, then the relative RF is assumed to be constant over the calibration range, and the
average relative RF may be used for quantitation (Sec. 11.7.2).
11.3.6.1 If the RSD of any target analyte is greater than 20%, refer to
Method 8000 for additional calibration options. One of the options must be applied
to GC/MS calibration in this situation, or a new initial calibration must be
performed. The RF should not be used for compounds that have an RSD greater
than 20% unless the concentration is reported as estimated.
11.3.6.2 When the RSD exceeds 20%, the plotting and visual
inspection of a calibration curve can be a useful diagnostic tool. The inspection
may indicate analytical problems, including errors in standard preparation, the
presence of active sites in the chromatographic system, analytes that exhibit poor
chromatographic behavior, etc.
11.4 GC/MS calibration verification - Calibration verification consists of three steps that
are performed at the beginning of each twelve hour analytical shift.
11.4.2 The initial calibration function for each target analyte should be checked
immediately after the first occurrence in the region of the middle of the calibration range
with a standard from a source different from that used for the initial calibration. The value
determined from the second source check should be within 30% of the expected
concentration. An alternative recovery limit may be appropriate based on the desired
project-specific DQOs. Quantitative sample analyses should not proceed for those
analytes that fail the second source standard initial calibration verification. However,
analyses may continue for those analytes that fail the criteria with an understanding that
these results could be used for screening purposes and would be considered estimated
values.
11.4.3 The initial calibration (Sec. 11.3) for each compound of interest should be
verified once every twelve hours prior to sample analysis, using the introduction technique
and conditions used for samples. This is accomplished by analyzing a calibration
standard (containing all the compounds for quantitation) at a concentration either near the
midpoint concentration for the calibrating range of the GC/MS or near the action level for
the project. The results must be compared against the most recent initial calibration curve
and should meet the verification acceptance criteria provided in Secs. 11.4.5 through
11.4.7.
NOTE: The DFTPP and calibration verification standard may be combined into a single
standard as long as both tuning and calibration verification acceptance criteria for
the project can be met without interferences.
11.4.5.2 If the minimum RFs are not met, the system should be
evaluated, and corrective action should be taken before sample analysis begins.
11.4.5.6 The method of linear regression analysis has the potential for
a significant bias to the lower portion of a calibration curve, while the relative
percent difference and quadratic methods of calibration do not have this potential
bias. When calculating the calibration curves using the linear regression model, a
minimum quantitation check on the viability of the lowest calibration point should be
performed by re-fitting the response from the low concentration calibration
standard back into the curve (see Method 8000 for additional details). It is not
necessary to re-analyze a low concentration standard; rather the data system can
recalculate the concentrations as if it were an unknown sample. The recalculated
concentration of the low calibration point should be within ± 30% of the standard's
true concentration. Other recovery criteria may be applicable depending on the
project's DQOs and for those situations the minimum quantitation check criteria
should be outlined in a laboratory SOP, or a project-specific QAPP. Analytes
which do not meet the minimum quantitation calibration re-fitting criteria should be
considered "out of control" and corrective action such as redefining the LLOQ
and/or reporting those "out of control" target analytes as estimated when the
concentration is at or near the lowest calibration point may be appropriate.
11.4.6 Internal standard retention time - The retention times of the internal
standards in the calibration verification standard must be evaluated immediately after or
during data acquisition. If the absolute retention time for any internal standard changes by
more than 30 sec from that in the mid-point standard level of the most recent initial
calibration sequence, then the chromatographic system must be inspected for
malfunctions and corrections must be made, as required. When corrections are made,
reanalysis of samples analyzed while the system was malfunctioning is required.
11.5.2 Allow the sample extract to warm to room temperature. Just prior to
analysis, add 10 µL of the internal standard solution to the 1 mL of concentrated sample
extract obtained from sample preparation.
11.5.3 Inject an aliquot of the sample extract into the GC/MS system, using the
same operating conditions that were used for the calibration (Sec. 11.3). The volume to
be injected should include an appropriate concentration that is within the calibration range
of base/neutral and acid surrogates using the surrogate solution as noted in Sec. 7.8. The
injection volume must be the same volume that was used for the calibration standards.
11.5.4 If the response for any quantitation ion exceeds the initial calibration
range of the GC/MS system, the sample extract must be diluted and reanalyzed.
Additional internal standard solution must be added to the diluted extract to maintain the
same concentration as in the calibration standards (usually 40 ng/µL, or other
concentrations as appropriate, if a more sensitive GC/MS system is being used).
Secondary ion quantitation should be used only when there are sample interferences with
the primary ion.
NOTE: It may be a useful diagnostic tool to monitor internal standard retention times in all
samples, spikes, blanks, and standards to effectively check drifting, method
performance, poor injection execution, and anticipate the need for system
inspection and/or maintenance. Internal standard responses (area counts) should
be monitored in all samples, spikes and blanks for similar reasons. If the EICP
area for any of the internal standards in samples, spikes, and blanks changes by a
factor of two (−50% to +100%) from the areas determined in the continuing
calibration analyzed that day, corrective action should be taken. The samples,
spikes, or blanks should be reanalyzed or the data should be qualified.
11.6.1.2 The RRT of the sample component is within ± 0.06 RRT units
of the RRT of the standard component.
11.6.2 For samples containing components not associated with the calibration
standards, a library search may be made for the purpose of tentative identification. The
necessity to perform this type of identification will be determined by the purpose of the
analyses being conducted. Data system library search routines should not use
normalization routines that would misrepresent the library or unknown spectra when
compared to each other.
For example, the RCRA permit or waste delisting requirements may require the
reporting of non-target analytes. Only after visual comparison of sample spectra with the
nearest library searches may the analyst assign a tentative identification. Guidelines for
tentative identification are:
(1) Relative intensities of major ions in the reference spectrum (i.e., ions > 10%
of the most abundant ion) should be present in the sample spectrum.
(2) The relative intensities of the major ions should agree within ± 30%. For
example, an ion with an abundance of 50% in the standard spectrum must
have a corresponding sample ion abundance between 20 and 80%.
(3) Molecular ions present in the reference spectrum should be present in the
sample spectrum.
(4) Ions present in the sample spectrum but not in the reference spectrum
should be reviewed for possible background contamination or presence of
co-eluting compounds.
(5) Ions present in the reference spectrum but not in the sample spectrum
should be reviewed for possible subtraction from the sample spectrum
because of background contamination or co-eluting peaks. Data system
library reduction programs can sometimes create these discrepancies.
11.7.1 Once a target compound has been identified, the quantitation of that
compound will be based on the integrated abundance of the primary characteristic ion
from the EICP.
11.7.4 The resulting concentration should be reported indicating that the value is
an estimate. Use the nearest internal standard free of interferences.
11.7.7 Structural isomers that produce very similar mass spectra should be
quantitated as individual isomers if they have sufficiently different gas chromatographic
retention times. Sufficient gas chromatographic resolution is achieved if the height of the
valley between two isomer peaks is less than 50% of the average of the two peak heights.
Otherwise, structural isomers are identified as isomeric pairs. The resolution should be
verified on the mid-point concentration of the initial calibration as well as the laboratory
designated continuing calibration verification level if closely eluting isomers are to be
reported (e.g., benzo(b)fluoranthene and benzo(k)fluoranthene).
SW-846 Update V 8270D - 28 Revision 5
July 2014
12.0 DATA ANALYSIS AND CALCULATIONS
See Sec. 11.7 and Method 8000 for information on data analysis and calculations.
13.1 Performance data and related information are provided in SW-846 methods only as
examples and guidance. The data do not represent required performance criteria for users of
the methods. Instead, performance criteria should be developed on a project-specific basis,
and the laboratory should establish in-house QC performance criteria for the application of this
method. These performance data are not intended to be and must not be used as absolute QC
acceptance criteria for purposes of laboratory accreditation.
13.2 Single laboratory initial demonstration of capability data were generated from five
replicate measurements using a modified continuous liquid-liquid extractor (Method 3520) with
hydrophobic membrane. In this case only a single acid pH extraction was performed using the
CLP calibration criteria and the applicable CLP target analytes. These data are presented in
Table 6. Laboratories should generate their own acceptance criteria depending on the
extraction and instrument conditions. See Method 8000 for more detailed guidance.
13.3 Chromatograms from calibration standards analyzed with Day 0 and Day 7
samples were compared to detect possible deterioration of gas chromatographic performance.
These recoveries (using Method 3510 extraction) are presented in Table 7. These data are
provided for guidance purposes only.
13.4 Method performance data using Method 3541 (i.e., automated Soxhlet extraction)
are presented in Tables 8 and 9. Single laboratory accuracy and precision data were obtained
for semivolatile organics in a clay soil by spiking at a concentration of 6 mg/kg for each
compound. The spiking solution was mixed into the soil during addition and then allowed to
equilibrate for approximately one hour prior to extraction. The spiked samples were then
extracted by Method 3541 (Automated Soxhlet). Three extractions were performed and each
extract was analyzed by GC/MS following Method 8270. The low recovery of the more volatile
compounds is probably due to volatilization losses during equilibration. These data as listed
were taken from Reference 7 and are provided for guidance purposes only.
13.5 Surrogate precision and accuracy data are presented in Table 10 from a field
dynamic spiking study based on air sampling by Method 0010. The trapping media were
prepared for analysis by Method 3542 and subsequently analyzed by this method (i.e., 8270).
These data are provided for guidance purposes only.
13.6 Single laboratory precision and bias data using Method 3545 (i.e., pressurized fluid
extraction) for semivolatile organic compounds are presented in Table 11. The samples were
conditioned spiked samples prepared and certified by a commercial supplier that contained 57
semivolatile organics at three concentrations (i.e., 250, 2500, and 12,500 µg/kg) on three types
of soil (i.e, clay, loam, and sand). Spiked samples were extracted both by the Dionex ASE
system and by the Perstorp Environmental SoxtecTM (i.e., automated Soxhlet). The data in
Table 11 represent seven replicate extractions and analyses for each individual sample and
were taken from Reference 9. The average recoveries from the three matrices for all analytes
and all replicates relative to the automated Soxhlet data are as follows: clay 96.8%, loam
98.7% and sand 102.1%. The average recoveries from the three concentrations also relative to
the automated Soxhlet data are as follows: low – 101.2%, mid – 97.2% and high – 99.2%.
These data are provided for guidance purposes only.
13.8 Single laboratory precision and accuracy using Method 3561 (i.e., SFE extraction
of PAHs with a fixed restrictor and liquid trapping) were obtained for twelve of the method
analytes by the extraction of a certified reference material (i.e., a soil naturally contaminated
with PAHs). The SFE instrument used for these extractions was a Dionex Model 703-M.
Analysis was by GC/MS. Average recoveries from four replicate extractions ranged from 60 to
122%, with an overall average of 89%, based on the certified value. The instrument conditions
that were utilized to extract a 3.4 g sample were as follows: Pressure - 300 atm; time - 60 min;
extraction fluid - CO2; modifier - 10% 1:1 (v/v) methanol/methylene chloride; Oven temperature -
80 °C; Restrictor temperature - 120 °C; and, trapping fluid - chloroform (methylene chloride has
also been used). The data are found in Table 14 and were taken from Reference 11. These
data are provided for guidance purposes only.
13.9 Tables 15 and 16 contain single-laboratory precision and accuracy data for solid-
phase extraction of TCLP buffer solutions spiked at two levels and extracted using Method
3535. These data are provided for guidance purposes only.
13.11 Tables 18 through 22 contain single-laboratory PAH recovery data for microwave
extraction of contaminated soils and standard reference materials using Method 3546. These
data are provided for guidance purposes only.
14.1 Pollution prevention encompasses any technique that reduces or eliminates the
quantity and/or toxicity of waste at the point of generation. Numerous opportunities for pollution
prevention exist in laboratory operations. The EPA has established a preferred hierarchy of
environmental management techniques that places pollution prevention as the management
option of first choice. Whenever feasible, laboratory personnel should use pollution prevention
techniques to address their waste generation. When wastes cannot be feasibly reduced at the
source, the Agency recommends recycling as the next best option.
14.2 For information about pollution prevention that may be applicable to laboratories
and research institutions consult Less is Better: Laboratory Chemical Management for Waste
Reduction, a free publication available from the ACS, Committee on Chemical Safety,
http://portal.acs.org/portal/fileFetch/C/WPCP_012290/pdf/WPCP_012290.pdf.
The EPA requires that laboratory waste management practices be conducted consistent
with all applicable rules and regulations. The Agency urges laboratories to protect the air,
water, and land by minimizing and controlling all releases from hoods and bench operations,
complying with the letter and spirit of any sewer discharge permits and regulations, and by
complying with all solid and hazardous waste regulations, particularly the hazardous waste
identification rules and land disposal restrictions. For further information on waste
management, consult The Waste Management Manual for Laboratory Personnel available from
the ACS at the web address listed in Sec. 14.2.
16.0 REFERENCES
2. P. Olynk, W. L. Budde, and J. W. Eichelberger, "Method Detection Limit for Methods 624
and 625," unpublished report, October 1980.
3. "Interlaboratory Method Study for EPA Method 625 - Base/Neutrals, Acids, and
Pesticides," Final Report for EPA Contract 68-03-3102.
11. S. Warner, "SFE Extraction of PNAs from Solid Matrices Using the Dionex 703M SFE
Extractor and a Liquid Trap," EPA Region III, Central Regional Laboratory, 839 Bestgate
Road, Annapolis, MD 21401, December 12, 1994.
12. C. Markell, "3M Data Submission to EPA," letter to B. Lesnik, June 27, 1995.
13. U.S. EPA Method 525.2, "Determination of Organic Compounds in Drinking Water by
Liquid-Solid Extraction and Capillary Column Gas Chromatography/Mass Spectrometry,"
Environmental Monitoring Systems Laboratory, Office of Research and Development, US
EPA, Cincinnati, OH, Revision 2.0, March 1995.
The following pages contain the tables and figures referenced by this method.
IS = internal standard
surr = surrogate
a
The data presented are representative of DB-5 type analytical columns.
b
Compounds cannot be separated for quantitation
c
Substitute for the non-specific mixture, tricresyl phosphate
ND = Not Determined
NA = Not Applicable
a
The majority of the data are taken from Reference 13 (Method 525.2).
b
The criteria in this table are intended to be used as default criteria for quadrupole
instrumentation if optimized manufacturer's operating conditions are not available.
Alternate tuning criteria may be employed (e.g., CLP or Method 625), provided that
method performance is not adversely affected. See Sec. 11.3.1.
Minimum Response
Semivolatile Compounds
Factor (RF)
Benzaldehyde 0.010
Phenol 0.800
Bis(2-chloroethyl)ether 0.700
2-Chlorophenol 0.800
2-Methylphenol 0.700
2,2'-Oxybis-(1-chloropropane) 0.010
Acetophenone 0.010
4-Methylphenol 0.600
N-Nitroso-di-n-propylamine 0.500
Hexachloroethane 0.300
Nitrobenzene 0.200
Isophorone 0.400
2-Nitrophenol 0.100
2,4-Dimethylphenol 0.200
Bis(2-chloroethoxy)methane 0.300
2,4-Dichlorophenol 0.200
Naphthalene 0.700
4-Chloroaniline 0.010
Hexachlorobutadiene 0.010
Caprolactam 0.010
4-Chloro-3-methylphenol 0.200
2-Methylnaphthalene 0.400
Hexachlorocyclopentadiene 0.050
2,4,6-Trichlorophenol 0.200
2,4,5-Trichlorophenol 0.200
1,1'-Biphenyl 0.010
2-Chloronaphthalene 0.800
2-Nitroaniline 0.010
Dimethyl phthalate 0.010
2,6-Dinitrotoluene 0.200
Acenaphthylene 0.900
3-Nitroaniline 0.010
Acenaphthene 0.900
2,4-Dinitrophenol 0.010
4-Nitrophenol 0.010
Dibenzofuran 0.800
2,4-Dinitrotoluene 0.200
Diethyl phthalate 0.010
1,2,4,5-Tetrachlorobenzene 0.010
4-Chlorophenyl-phenyl ether 0.400
Fluorene 0.900
4-Nitroaniline 0.010
4,6-Dinitro-2-methylphenol 0.010
4-Bromophenyl-phenyl ether 0.100
N-Nitrosodiphenylamine 0.010
Hexachlorobenzene 0.100
(surr) = surrogate
(surr) = surrogate
3-Amino-9-ethylcarbazole 80 8 73 3
4-Chloro-1,2-phenylenediamine 91 1 108 4
4-Chloro-1,3-phenylenediamine 84 3 70 3
1,2-Dibromo-3-chloropropane 97 2 98 5
Dinoseb 99 3 97 6
Parathion 100 2 103 4
4,4'-Methylenebis(N,N-
dimethylaniline) 108 4 90 4
5-Nitro-o-toluidine 99 10 93 4
2-Picoline 80 4 83 4
Tetraethyl dithiopyrophosphate 92 7 70 1
a
The operating conditions for the Soxtec apparatus were as follows: immersion time 45 min;
the sample size was 10 g; the spiking concentration was 500 ng/g, except for the surrogate
compounds at 1000 ng/g, 2,5-Dichlorophenyl-4-nitrophenyl ether, 2,3,6-Trichlorophenyl-4-
nitrophenyl ether, and 2,3,4-Trichlorophenyl-4-nitrophenyl ether at 1500 ng/g, Nitrobenzene at
2000 ng/g, and 1,3-Dichlorobenzene and 1,2-Dichlorobenzene at 5000 ng/g.
a
Number of determinations was three. The operating conditions for the Soxtec apparatus were
as follows: immersion time 45 min; the sample size was 10 g clay soil; the spike concentration
was 6 mg/kg per compound. The sample was allowed to equilibrate 1 hour after spiking.
a
The surrogate values shown in Table 10 represent mean recoveries for surrogates in all
Method 0010 matrices in a field dynamic spiking study.
*Values greater than 150% were not used to determine the averages, but the 0% values were used.
a
RSDs for the SFE values are based on six replicate extractions.
b
Values in parentheses were obtained from, or compared to, Soxhlet extraction results which
were not certified.
a
RSDs for the SFE values are based on three replicate extractions.
a
RSDs for the SFE values are based on four replicate extractions.
1,4-Dichlorobenzene 3,750 63 10 63 9
Hexachloroethane 1,500 55 6 77 4
Nitrobenzene 1,000 82 10 100 5
Hexachlorobutadiene 250 65 3 56 4
2,4-Dinitrotoluene 65 89 4 101 5
Hexachlorobenzene 65 98 5 95 6
o-Cresol 100,000 83 10 85 5
m-Cresol* 100,000 86 8 85 3
p-Cresol* 100,000 * * * *
2,4,6-Trichlorophenol 1,000 84 12 95 12
2,4,5-Trichlorophenol 200,000 83 11 88 3
Pentachlorophenol 50,000 82 9 78 9
*In this study, m-cresol and p-cresol co-eluted and were quantified as a mixture of both isomers.
1,4-Dichlorobenzene 15,000 63 10 63 9
Hexachloroethane 6,000 54 7 46 7
Nitrobenzene 4,000 81 4 81 13
Hexachlorobutadiene 1,000 81 5 70 11
2,4-Dinitrotoluene 260 99 8 98 3
Hexachlorobenzene 260 89 8 91 9
o-Cresol* 400,000 92 15 90 4
m-Cresol* 400,000 95 8 82 6
p-Cresol* 400,000 82 14 84 7
2,4,6-Trichlorophenol 4,000 93 12 104 12
2,4,5-Trichlorophenol 800,000 93 14 97 23
Pentachlorophenol 200,000 84 9 73 8
*In this study, recoveries of these compounds were determined from triplicate spikes of the
individual compounds into separate buffer solutions.
(continued)
* 250-mL aliquots of leachate were spiked. Lab 1 spiked at one-half these levels.
** m-Cresol and p-Cresol co-elute. Lab 1 and Lab 3 reported o-Cresol and the sum of m- and p-
Cresol. Lab 2 reported the sum of all three isomers of Cresol.
n=4
Soil samples obtained from U.S. EPA Emergency Response Center archive bank through their
Response Engineering and Analytical Contract (REAC) laboratory (Edison, NJ). The standard
Soxhlet extraction procedures were performed by REAC three years earlier; this long storage
period is believed to account for the low naphthalene recovery data in the present study.
n=3
Naphthalene 150 * 54
Acenaphthylene 150 * 82
Acenaphthene 150 * 63
Fluorene 150 * 81
Phenanthrene 680 600 - 760 81
Anthracene 140 70 - 210 108
Fluoranthene 1250 1,150 - 1,350 84
Pyrene 940 820 - 1,060 85
Benzo(a)anthracene 530 470 - 580 78
Chrysene 650 570 - 730 84
Benzo(b)fluoranthene 700 550 - 850 84
Benzo(k)fluoranthene 360 310 - 410 156
Benzo(a)pyrene 650 570 - 730 73
Indeno(1,2,3-cd)pyrene 510 360 - 660 88
Dibenz(a,h)anthracene 120 70 - 170 117
Benzo(g,h,i)perylene 580 360 - 800 91
n=3
n=3
n=3
1. Improved overall method formatting for consistency with new SW-846 methods style
guidance. The format was updated to Microsoft Word .docx.
2. Many minor editorial and technical revisions were made throughout to improve method
clarity.
3. The revision number was changed to 5 and the date published was changed to July
2014.
4. This appendix was added showing changes from the previous revision.
5. Chemical name was changed by the Integrated Risk Information System (IRIS) on
November 30, 2007 from Bis(2-chloroisopropyl)ether to Bis(2-chloro-1-methylethyl)ether
(common name). This compound is also known as 2,2’-oxybis(1-chloropropane) (CAS
index name). See the link at http://www.epa.gov/iris/subst/0407.htm, Section VII for the
“Revision History” and Section VIII, for “Synonyms” of this chemical.
6. Updated information on LLOQ and method blank evaluation was included based on
language found in Method 8000D.